Police Hunt Woman Selling Fake Ozempic and Mounjaro
A nationwide manhunt is underway for a woman allegedly selling fake diabetes and weight-loss medications online. Authorities warn of severe health risks from counterfeit semaglutide injections.
Category : Search result: pharmaceutical companies
Met Police charge 14 over Palestine Action protests
The Metropolitan Police has charged 14 individuals following a series of disruptive protests by the outlawed group Palestine Action at defence company sites across England. The group is accused of targeting Israeli-linked defence firms.
Trump Accuses Big Pharma of COVID Cover-Up in Debate
In a fiery debate revelation, Donald Trump accuses pharmaceutical giants of a COVID-19 cover-up, vowing to force transparency on the pandemic's origins if re-elected. RFK Jr. backs the claim, igniting a new political firestorm.
PM's Finance Guru Paid Zero Tax, Companies Dissolved
Exclusive investigation reveals the Prime Minister's new business adviser, Andrew Griffith, paid no wealth taxes last year and has a complex corporate history with dissolved companies, raising questions about his No. 10 appointment.
AstraZeneca's Revolutionary Blood Pressure Pill Shows Promise
A groundbreaking new hypertension drug, Baxdrostat, developed by AstraZeneca, has demonstrated remarkable success in clinical trials, potentially offering new hope for millions with treatment-resistant high blood pressure in the UK.
Trump Tariffs Threaten UK Ozempic and Mounjaro Supplies
Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.
UK Mounjaro Crisis: Eli Lilly Halts Shipments, Price Soars
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
Streeting's Tough Stance on Pharma Deal Sparks Industry Backlash
Health Secretary Wes Streeting takes hardline stance in crucial NHS drug pricing negotiations with pharmaceutical giants, demanding better value for taxpayers while facing industry resistance.
Trump Tariffs Threaten UK Access to Weight-Loss Drugs
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
Streeting Confronts Pharma Giants Over NHS Drug Pricing
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
OnlyFans parent company secretly registered at UK Companies House
The parent company of adult content platform OnlyFans, Fenix International, has been discreetly registered at UK Companies House with a hidden ownership structure, raising questions about corporate transparency.
England's Water Crisis: The Leaking Truth
Exclusive analysis reveals how decades of underinvestment, rampant leaks, and failed regulation have pushed England's water system to the brink of collapse. Discover the radical solutions needed to avert a national disaster.
Novartis Accused of Exploiting WHO Scheme in Africa
An explosive investigation reveals how pharmaceutical giant Novartis leveraged a WHO-led initiative to push its expensive cancer drug in Nigeria and Kenya, raising serious ethical concerns about Big Pharma's role in public health.
Mounjaro and Ozempic prices surge amid high demand
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Ozempic & Mounjaro Prices Rise Due to Trump Tariffs
Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.
UK firms linked to Hong Kong President in Companies House
Several businesses in Liverpool and Manchester have been connected to the President of Hong Kong through filings at Companies House, raising eyebrows in the business community.
Eli Lilly hikes Mounjaro price in UK for 2025
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.
Pam Bondi Under Fire for Alleged Pharma Lobbying
Former Florida Attorney General Pam Bondi faces ethics complaints for allegedly lobbying the Justice Department on behalf of a pharmaceutical company while serving on a federal drug enforcement board.
Pharma exec charged in fatal wrong-way crash
A pharmaceutical executive faces charges after a horrific wrong-way collision claimed the life of a former Olympic swimmer. The shocking incident has sent shockwaves through the community.
Mounjaro maker tackles UK obesity with new programme
The pharmaceutical giant behind Mounjaro unveils an ambitious initiative to combat obesity in the UK, offering hope for millions struggling with weight-related health issues.
Eli Lilly developing weight loss pill to rival injections
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Delhi fake drug racket targets J&J and GSK products
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
FDA approves groundbreaking Alzheimer's drug
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
European Pharma Stocks Hit 3-Month Low on Tariff Fears
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Novo Nordisk diabetes drug sales slow sharply
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Trump's pharma tariffs could hit UK drug prices
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Trump’s Plan to Slash Drug Prices Sparks Big Pharma Backlash
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Ofwat criticised over water pollution failures
Water regulator Ofwat faces criticism as government advisers accuse it of failing to curb pollution, sparking a heated debate over environmental protections.
Ofwat examines £13m paid to Yorkshire Water boss offshore
Ofwat is probing £13m in payments made to Yorkshire Water CEO Nicola Shaw via an offshore parent company, raising concerns over transparency and executive pay in the utilities sector.
Starmer's bold plan to cut UK drug prices
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Page 1 of 3